Concepedia

Evis Havari

EH

12

Publications

558

Citations

12

H-Index

2001

Active since

Affiliations

Harvard University(Current)

Brigham and Women's Hospital

Joslin Diabetes Center

Gene Therapy Laboratory

Sanofi (United States)

Evis Havari is an author at Harvard University specializing in medicine, immunology, and cell biology.

Top concepts

Publications per year

2001–2024

12

Publications

12

Impaired thymic tolerance to α-myosin directs autoimmunity to the heart in mice and humans

Huijuan Lv, Evis Havari, Sheena Pinto et al. · Journal of Clinical Investigation · 2011 · 212 citations · Full text

, , +29

Impact of alemtuzumab treatment on the survival and function of human regulatory <scp>T</scp> cells <i>in vitro</i>

Evis Havari, Michael J. Turner, Juanita Campos‐Rivera et al. · Immunology · 2013 · 70 citations · Full text

A Spontaneous Model for Autoimmune Myocarditis Using the Human MHC Molecule HLA-DQ8

Jacqueline Taylor, Evis Havari, Marcia F. McInerney et al. · The Journal of Immunology · 2004 · 57 citations

Immune status following alemtuzumab treatment in human CD52 transgenic mice

Michael J. Turner, Michael LaMorte, Nathalie Chrétien et al. · Journal of Neuroimmunology · 2013 · 55 citations

Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing–remitting MS

Jens Kühle, Nadia Daizadeh, Pascal Benkert et al. · Multiple Sclerosis Journal · 2021 · 31 citations · Full text

Rows per page

1–5 of 12